translational medicine director (metabolisim).

about the company.
A top-tier domestic pharmaceutical company.

about the job.

1. Pharmacology and Efficacy Studies:

• Lead the selection and development of pharmacology and efficacy models for Endocrinology and Metabolism drug projects.
• Utilize internal and external resources to design relevant in vivo experiments based on the project’s development stage to support R&D decision-making.
• Collaborate with project leaders to track experiment progress and interpret data.

1. Target Biology and Translational Research:

• Quickly familiarize with and master the biological mechanisms of project targets and required translational research plans.
• Propose and develop methods and feasible implementation plans for preclinical in vivo mechanism studies.

1. Competitive Intelligence Tracking:

• Regularly track competitive information for ongoing projects.
• Summarize and update relevant clinical or preclinical progress to provide important reference points for project team decisions.

1. Project Management and Internal Resource Coordination:

• Manage R&D outsourcing activities for relevant projects.
• Coordinate and communicate with internal platform resources to ensure experimental plans can be smoothly executed.

skills and experience required.

• Ph.D. or MD/Ph.D. in Endocrinology and Metabolism, Translational Medicine, Pharmacology, or a related field. Advanced degrees in related disciplines may be considered with appropriate experience.
• Experience: 10+ years of experience in Endocrinology and Metabolism and translational research, with at least 2 years in a leadership role within pharmaceutical or biotechnology industries.
• Proven track record of leading translational research teams and managing complex projects.
• Extensive experience with preclinical and clinical research methodologies.
• Preferred with experience in precision medicine and personalized immunotherapy approaches.
• Demonstrated expertise in pharmacology, in vivo models, and Endocrinology and Metabolism drug development.